2192. Comparative Antimicrobial Susceptibility of Gram-Negative Bacteria Isolated from Patients with Bloodstream Infections and Pneumonia when Tested against Tazobactam Combinations

BACKGROUND: Cefepime–tazobactam (FEP-TAZ) is in clinical development at 2g/2g q8 hours administered over 90 minutes (high-dose extended infusion). We compared the susceptibility (S) of Gram-negative bacilli (GNB) from patients with bloodstream infections (BSI) and pneumonia (PN) against FEP-TAZ, pip...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalhaes, Cecilia G, Mendes, Rodrigo E, Flamm, Robert K, Sader, Helio S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809804/
http://dx.doi.org/10.1093/ofid/ofz360.1872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809804/
http://dx.doi.org/10.1093/ofid/ofz360.1872

Ejemplares similares